SCHEMBL10201150

SCHEMBL10201150

Cn1nc(-c2ccco2)cc1-c1ccc(C(=O)Nc2ccccc2F)s1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STIM1 Q13586 7/20 0.68
ORAI1 Q96D31 7/20 0.68
SMN1; SMN2 Q16637 2/20 0.50
TP53 P04637 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.48
ESR1 P03372 2/20 0.47
ESRRG P62508 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
MCL1 Q07820 1/20 0.47
ESR2 Q92731 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10201116 0.90 STIM1 (0.67) STIM1ORAI1KDM4EALDH1A1RAB9A
SCHEMBL10201608 0.89 STIM1 (0.57) STIM1ORAI1KDM4EALDH1A1RAB9A
SCHEMBL10201161 0.89 STIM1 (0.54) STIM1ORAI1ESR1ESRRGKDM4E
SCHEMBL10201138 0.86 STIM1 (0.74) STIM1ORAI1KDM4EALDH1A1RAB9A
SCHEMBL10201603 0.86 STIM1 (0.73) STIM1ORAI1KDM4EALDH1A1RAB9A
SCHEMBL10201178 0.85 STIM1 (0.75) STIM1ORAI1SMN1; SMN2TP53ESR1
SCHEMBL10201139 0.85 STIM1 (0.70) STIM1ORAI1SMN1; SMN2TP53ESR1
SCHEMBL10201146 0.83 STIM1 (0.57) STIM1ORAI1KDM4EALDH1A1RAB9A
SCHEMBL10201118 0.83 STIM1 (0.67) STIM1ORAI1SMN1; SMN2TP53ESR1
SCHEMBL10201609 0.82 STIM1 (0.56) STIM1ORAI1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336738-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2019-07-02 US disclosed
US-20150344469-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM AVENUE CAPITAL MANAGEMENT II, L.P. 2015-12-03 US disclosed
US-20150344469-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM AVENUE CAPITAL MANAGEMENT II, L.P. 2015-12-03 US disclosed
US-9079891-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2015-07-14 US disclosed
US-9079891-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2015-07-14 US disclosed
US-20120053210-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2012-03-01 US disclosed
US-20120053210-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2012-03-01 US disclosed
WO-2012027710-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336738-B2 Compounds that modulate intracellular calcium ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885SMN1; SMN2 854/4885
US-20150344469-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885SMN1; SMN2 854/4885
US-20120053210-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885SMN1; SMN2 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.